Table 3.
Author | Design | SCU vs. n-SCU, n | Results | Assessment instrument | p value | Cohen's d (baseline) |
---|---|---|---|---|---|---|
Orfaly Cadigan [44] | longitudinal, controlled | 141 vs. 31 | – functional status | BANS-S [88] | 0.0001 | not available |
De Rooij [10] | quasi-experimental, longitudinalc | 51 vs. 51 | – functional status | Barthel index [52] | not available | −0.58 |
30 vs. 47 | −0.53 | |||||
Abrahamson [39] | random, cross-sectional | 665 vs. 12,442 | – functional level | MDS ADL [82] | 0.433 | 0.03 |
Verbeek [12] | quasi-experimental, longitudinal, controlledc | 124 vs. 135 | – ADL | ADL-H [82] | n.s. | −0.13 |
Verbeek [11] | cross-sectional | 586 vs. 183 | – functional status | MDS [82] | n.s. | 10.72 |
Weyerer [31] | cross-sectional, randomly selected, matched | 594 vs. 573 | – ADL | Barthel index | <0.05 | −0.12 |
Te Boekhorst [13] | quasi-experimental, longitudinal, controlledc | 67 vs. 97 | – ADL | IDDD [89] | <0.01a | not available |
Nobili [9] | longitudinal, comparative | 72 vs. 72 | – functional status | Barthel index | 0.0005a | 0.56 |
Pekkarinen [33] | cross-sectional, selection by characteristics | 390 vs. 587 | – assistance in ADL | MDS ADL | 0.05 | 0.46 |
Ashcraft [27] | cross-sectional | 15 vs. 15 | – ADL | MDS ADL | not available | −0.30 |
Sloane [32] | cross-sectional, random | 773 vs. 479 | – ADL impairment | MDS ADL | 0.001 | −0.021 |
Reimer [14] | matched groups designd | 62 vs. 59 | – functional status | FAST [90] | 0.016 | not available |
Luo [8] | cross-sectional | 750 vs. 3,667 | – ADL | no standardized instrumentb | >0.01 | −5.70 |
Warren [38] | longitudinal, controlled | 44 vs. 36 | – physical status (ADL) | FAM + FIM [59] | not available | −2.30 |
Chappel [25] | experimental | total: 323 | – physical functioning | MDS ADL | <0.01 | 0.176c |
Leon [21] | experimental field study | 432 vs. 164 | – ADL limitations | MDS ADL | n.s. | 0.07 |
Frisoni [34] | longitudinal, controlled | 31 vs. 35 | – function | Barthel index | not available | 0.31 |
Saxton [15] | longitudinal, matched, controlledd | 26 vs. 19 | – total ADL | FIM | n.s.a | 5.5 |
– self-care | <0.05a | 0.11 | ||||
Phillips [45] | longitudinal, matched, controlled | 1,228 vs. 5,904 vs. 70,205 | – ADL function | MDS ADL | n.s.a | not available |
Volicer [41] | prospective cohort study | 50 vs. 112 | – ADL | Katz ADL index [91 | n.s. | 0.01 |
Swanson [35] | quasi-experimental, pre-/post-tests | 13 vs. 9 | – functional ability Ib | FAC/ GRS [61] | n.s.* | 0.45 |
– functional ability IIb | n.s.* | 0.03 | ||||
Lindesay [28] | cross-sectionale | 27 vs. 29 | – dressing | ABRS [78] | not available | 0.71 |
– washing | 1.02 | |||||
– feeding | 0.36 | |||||
– toileting | 0.41 | |||||
– mobility | 0.32 | |||||
Chafetz [46] | quasi-experimental, longitudinal | 12 vs. 8 | – ADL | Katz ADL index | n.s.a | not available |
Holmes [20] | quasi-experimental | 49 vs. 44 | – ADL | Katz ADL index | n.s.b | 0.15 |
Coleman [43] | experimental | 47 vs. 36 | – ADL functional level | Katz ADL index | <0.01 | not available |
MDS ADL = Morris scale; IDDD = Interview for the Deterioration of Daily Living Activities in Dementia; ADL-H = MDS; FAC = Functional Ability Checklist; GRS = Assessment Functioning of Geriatric Patients; ABRS = Adaptive Behaviour Rating Scale; BANS-S = Bedford Alzheimer's Nursing Severity-Subscale; n.s. = not significant.
Over time;
ADLs dependence was measured by the degree of dependence in five ADL (transferring, eating, toileting, dressing, bathing);
small-scale, homelike SCU/SCU comparison;
small-scale, homelike/n-SCU comparison;
SCU/n-SCU with mixed-sex population.